Cargando…

Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy

Multiple sclerosis (MS) is a leading cause of chronic neurological disability in young to middle-aged adults, affecting ~2.5 million people worldwide. Currently, most therapeutics for MS are systemic immunosuppressive or immunomodulatory drugs, but these drugs are unable to halt or reverse the disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansilla, M. J., Presas-Rodríguez, S., Teniente-Serra, A., González-Larreategui, I., Quirant-Sánchez, B., Fondelli, F., Djedovic, N., Iwaszkiewicz-Grześ, D., Chwojnicki, K., Miljković, Đ., Trzonkowski, P., Ramo-Tello, C., Martínez-Cáceres, E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167140/ https://www.ncbi.nlm.nih.gov/pubmed/33958746 http://dx.doi.org/10.1038/s41423-020-00618-z

Ejemplares similares

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2021)

Optimal response to dimethyl fumarate is mediated by a reduction of Th1‐like Th17 cells after 3 months of treatment
por: Mansilla, María José, et al.
Publicado: (2019)

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
por: Navarro-Barriuso, Juan, et al.
Publicado: (2019)

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4(+) Cells Towards a Functional Hyporesponsiveness
por: Navarro-Barriuso, Juan, et al.
Publicado: (2021)

Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator
por: Mansilla, María José, et al.
Publicado: (2021)

Th1Th17(CM) Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2019)

Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin
por: Navarro-Barriuso, Juan, et al.
Publicado: (2018)

Cell-Based Therapies with T Regulatory Cells
por: Gliwiński, Mateusz, et al.
Publicado: (2017)

Regulatory T Cells-Related Genes Are under DNA Methylation Influence
por: Piotrowska, Magdalena, et al.
Publicado: (2021)

Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers
por: Ortega-Hernandez, Oscar-Danilo, et al.
Publicado: (2023)

Characterization of recent thymic emigrants (RTEs), transitional B and Th17 cells in multiple sclerosis (MS)
por: Teniente-Serra, Aina, et al.
Publicado: (2011)

Paving the way toward better peer review
Publicado: (2016)

Therapy with CD4(+)CD25(+) T regulatory cells – should we be afraid of cancer?
por: Gliwiński, Mateusz, et al.
Publicado: (2019)

Antigenic Challenge Influences Epigenetic Changes in Antigen-Specific T Regulatory Cells
por: Iwaszkiewicz-Grzes, Dorota, et al.
Publicado: (2021)

Paving the way to metastasis
por: Van Epps, Heather L.
Publicado: (2005)

Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab
por: Granell-Geli, Júlia, et al.
Publicado: (2021)

Community-acquired pneumonia: paving the way towards new vaccination concepts
por: Becker, Pablo D., et al.
Publicado: (2007)

Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine
por: Antonatos, Charalabos, et al.
Publicado: (2023)

Paving the Way for Apollo 11
por: Harland, David M
Publicado: (2009)

Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome
por: Rival, Manon, et al.
Publicado: (2022)

Paving the Way Towards a Successful and Fulfilling Career in Computational Biology
por: Oluwagbemi, Olugbenga, et al.
Publicado: (2014)

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
por: Sancho-Saldaña, Agustín, et al.
Publicado: (2022)

Nuclear spindles pave the way to metastasis
por: Hensley, Patrick J., et al.
Publicado: (2017)

Amyotrophic Lateral Sclerosis Genetic Access Program: Paving the Way for Genetic Characterization of ALS in the Clinic
por: Roggenbuck, Jennifer, et al.
Publicado: (2021)

Paving the way for the oncological process in patients with schizophrenia
por: Casanovas, F., et al.
Publicado: (2021)

Homogeneous Kähler manifolds: paving the way towards new supersymmetric sigma models
por: Bordemann, Martin, et al.
Publicado: (1986)

Two-dimensional semiconductors pave the way towards dopant-based quantum computing
por: Abadillo-Uriel, José Carlos, et al.
Publicado: (2018)

Dementia in Latin America: Paving the way toward a regional action plan
por: Parra, Mario Alfredo, et al.
Publicado: (2020)

Endophytic Fungi-Mediated Biocatalysis and Biotransformations Paving the Way Toward Green Chemistry
por: Choudhary, Malvi, et al.
Publicado: (2021)

Paving the Way towards Sustainability of Polyurethanes: Synthesis and Properties of Terpene-Based Diisocyanate
por: Delavarde, Aliénor, et al.
Publicado: (2023)

Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents
por: Walczak, Juliusz Maksymilian, et al.
Publicado: (2022)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change
por: Zuluaga, Paola, et al.
Publicado: (2022)

Identifying Changes in Peripheral Lymphocyte Subpopulations in Adult Onset Type 1 Diabetes
por: Teniente-Serra, Aina, et al.
Publicado: (2021)

Hydraulic Fracturing: Paving the Way for a Sustainable Future?
por: Chen, Jiangang, et al.
Publicado: (2014)

Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
por: Djedovic, Neda, et al.
Publicado: (2019)

Proteomics paves the way for Q fever diagnostics
por: Kowalczewska, Malgorzata, et al.
Publicado: (2011)

Cern paves the way for lightning-speed networks
Publicado: (2008)

Cytokines in Bipolar Disorder: Paving the Way for Neuroprogression
por: Barbosa, Izabela Guimarães, et al.
Publicado: (2014)

BioMiner: Paving the Way for Personalized Medicine
por: Bauer, Chris, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_br1tj2sq9gduelp2c1c2oaa63a